-
Clinical Development
Best practices for biosafety assessment in immunotherapies. Regulatory considerations for biosafety
...
-
Translational Immunology
-
Immune Regulation
Autologous vs allogeneic Treg cell therapies - which one first and why? Discuss pros/cons of each on
...
-
Immunogenicity
What are the common immunogenicity risks across different biotherapeutic modalities (monoclonal anti
...
-
-
Clinical Development
-
Immune Regulation
-
Immunogenicity
-
Translational Immunology
Afternoon Refreshments
-
Translational Immunology
Biological complexity Technical challenges Omics Data integration strategy Multi-omics strategy for
...
-
-
Clinical Development
-
Immune Regulation
-
Immunogenicity
-
Translational Immunology
Evening Drinks Reception
-
-
Clinical Development
-
Immune Regulation
-
Immunogenicity
-
Translational Immunology
1-2-1 Meetings / Networking Break
-
-
Clinical Development
-
Immune Regulation
-
Immunogenicity
-
Translational Immunology
1-2-1 Meetings / Networking Break
-
-
Clinical Development
-
Immune Regulation
-
Immunogenicity
-
Translational Immunology
Potency assays measure the biological activity of biological products, providing data on drug dose,
...
-
-
Clinical Development
-
Immune Regulation
-
Immunogenicity
-
Translational Immunology
Networking Lunch
-
Translational Immunology
Key current challenges in Immunotherapy trials Brainstorming root causes and potential mitigation me
...
-
-
Clinical Development
-
Immune Regulation
-
Immunogenicity
-
Translational Immunology
Morning Refreshments
-
-
Clinical Development
-
Immune Regulation
-
Immunogenicity
-
Translational Immunology
1-2-1 Meetings / Networking Break
-
-
Clinical Development
-
Immune Regulation
-
Immunogenicity
-
Translational Immunology
1-2-1 Meetings / Networking Break
-
Immune Regulation
Targeting Myeloid-Derived Suppressor Cells(MDSCs) Repolarizing Tumor-Associated Macrophage(TAMs) Dep
...
-
Clinical Development
Southern Research offers a robust platform for evaluating immunotherapies through integrated preclin
...
-
Immunogenicity
Biotherapeutic modalities – What are the Inherent immunogenicity potentials and their relevance? Sho
...
-
-
Clinical Development
-
Immune Regulation
-
Immunogenicity
-
Translational Immunology
With over 300 antibody-drug conjugates (ADCs), immune-oncology (IO) agents, and T-cell engagers curr
...
-
-
Clinical Development
-
Immune Regulation
-
Immunogenicity
-
Translational Immunology
Registration
)
Potency assays measure the biological activity of biological products, providing data on drug dose, ...
)
Southern Research offers a robust platform for evaluating immunotherapies through integrated preclin ...)
With over 300 antibody-drug conjugates (ADCs), immune-oncology (IO) agents, and T-cell engagers curr ...
)
)
)
)
)
)
)
